Betta Pharmaceuticals Co., Ltd. (SHE:300558)

Betta Pharmaceuticals Revenue

Betta Pharmaceuticals had revenue of 985.93M CNY in the quarter ending September 30, 2025, with 16.83% growth. This brings the company's revenue in the last twelve months to 3.26B, up 18.40% year-over-year. In the year 2024, Betta Pharmaceuticals had annual revenue of 2.89B with 17.74% growth.

• Revenue (ttm): 3.26B
• Revenue Growth: +18.40%
• P/S Ratio: 5.89
• Revenue / Employee: 1.66M
• Employees: 1,961
• Market Cap: 19.23B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.89B	435.75M	17.74%
Dec 31, 2023	2.46B	79.57M	3.35%
Dec 31, 2022	2.38B	130.77M	5.82%
Jan 1, 2022	2.25B	375.59M	20.08%
Dec 31, 2020	1.87B	316.34M	20.36%